Lee Hambright analyst BERNSTEIN

Currently out of the existing stock ratings of Lee Hambright, 17 are a HOLD (51.52%), 15 are a BUY (45.45%), 1 are a SELL (3.03%).

Lee Hambright

Work Performance Price Targets & Ratings Chart

Analyst Lee Hambright, currently employed at BERNSTEIN, carries an average stock price target met ratio of 65% that have a potential upside of 22.94% achieved within 272 days.

Lee Hambright’s has documented 66 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DXCM, DexCom at 26-Jun-2023.

Wall Street Analyst Lee Hambright

Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 7/13/2020. The price target of $208.33 was fulfilled within 4 days with a profit of $17.9 (9.4%) receiving and performance score of 23.5.

Average potential price target upside

EW Edwards Lifesciences Corp MDT Medtronic PLC JNJ Johnson & Johnson ZBH Zimmer Biomet Holdings SYK Stryker ABT Abbott Laboratories ISRG Intuitive Surgical DXCM DexCom

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$20.04 (28.64%)

101

1 months 5 days ago

17/23 (73.91%)

$27.63 (44.30%)

219

Hold

77

$7.04 (10.06%)

81

1 months 6 days ago

10/14 (71.43%)

$17.3 (28.98%)

117

Buy

70

$0.04 (0.06%)

77

1 months 6 days ago

4/5 (80%)

$10.3 (17.25%)

58

Buy

85

$15.04 (21.50%)

103

1 months 6 days ago

4/6 (66.67%)

$25.3 (42.38%)

86

Buy

72

$2.04 (2.92%)

84

1 months 6 days ago

2/5 (40%)

$12.3 (20.60%)

51

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Lee Hambright?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?